Biocryst stock news
WebGlobeNewswire. BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral … WebApr 8, 2024 · What happened. Shares of BioCryst Pharmaceuticals ( BCRX) were crashing 32.9% lower as of 10:38 a.m. ET on Friday. The steep decline came after the company …
Biocryst stock news
Did you know?
WebApr 12, 2024 · April 12, 2024 - 7:00 am. RESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today … WebFeb 7, 2024 · PDF Version. Mar 29, 2024. BioCryst Celebrates Bob Ingram’s Contributions to the Company’s Success. PDF Version. Mar 02, 2024. BioCryst Reports Inducement …
WebFeb 23, 2024 · BioCryst (BCRX) delivered earnings and revenue surprises of -29.03% and 2.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? WebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of the company's stock in a transaction that occurred on Wednesday, February 1st. The stock was sold at an average price of $10.38, for a total transaction of $1,038,000.00. ... Hedge funds and other institutional investors own 79.05% of the …
WebBased on 8 Wall Street analysts offering 12 month price targets for BioCryst in the last 3 months. The average price target is $15.25 with a high forecast of $30.00 and a low forecast of $8.00 . The average price target represents a 75.69% change from the last price of $8.68 . WebBCRX Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
WebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of the company's stock in a transaction that occurred on Wednesday, …
WebMay 21, 2024 · During the first three months of 2024, sales of the injection reached an annualized rate of $3.2 billion. So for BioCryst, capturing just a fraction of the … grapevine communication is associated withWebRESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following investor conferences: The 22 nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19 th at 8:45 a.m. ET. The BofA Securities 2024 Health … chips act doeWebApr 6, 2024 · Financial Performance. In 2024, BCRX's revenue was $270.83 million, an increase of 72.31% compared to the previous year's $157.17 million. Losses were -$247.12 million, 34.3% more than in 2024. Financial Statements. chips act eligibilityWebFind the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. chips act diversityWebMay 4, 2024 · On May 5, BioCryst Pharmaceuticals will report earnings from the Q1. 12 analysts predict losses of $0.363 per share compared to losses of $0.360 per share in the same quarter of the previous year ... grapevine communication meaningWebNov 22, 2024 · Royalty Pharma also has extended its relationship with BioCryst through a $50 million equity investment at a price of $13.00 per share, the volume-weighted average price of BioCryst common stock ... grapevine commercial cleaning companyWebMar 29, 2024 · Stock Information. Stock Quote & Chart; Historic Stock Lookup; Investment Calculator; Finance & Filings. ... Recent News. Stay up to date with the latest discoveries, events, and reports from BioCryst. April 12, 2024 BioCryst to Present at Upcoming Investor Conferences April 4, 2024 grapevine communication relates to